Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Full Paper
  • Published:

A promoter polymorphism in the gene encoding interleukin-12 p40 (IL12B) is associated with mortality from cerebral malaria and with reduced nitric oxide production

Abstract

Interleukin-12 (IL-12) is an important regulatory cytokine in infection and immunity. Administration of IL-12 may reduce complications of severe malaria in rodents. Polymorphisms in IL12B, the gene encoding the IL-12 p40 subunit, influence the secretion of IL-12 and susceptibility to Type 1 diabetes. We therefore investigated whether IL12B polymorphisms may affect the outcome of severe malaria. Homozygosity for a polymorphism in the IL12B promoter was associated with increased mortality in Tanzanian children having cerebral malaria but not in Kenyan children with severe malaria. Furthermore, homozygotes for the IL12B promotor polymorphism had decreased production of nitric oxide, which is in part regulated by IL-12 activity. These studies suggest that IL12B polymorphisms, via regulation of IL-12 production, may influence the outcome of malaria infection in at least one African population.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Marsh K, Forster D, Waruiru C et al. Indicators of life-threatening malaria in African children N Engl J Med 1995 332: 1399–1404

    Article  CAS  Google Scholar 

  2. Gately MK, Renzetti LM, Magram J, Stern AS, Gubler U, Presky DH . The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses Annu Rev Immunol 1998 16: 495–521

    Article  CAS  Google Scholar 

  3. Mohan K, Sam H, Stevenson MM . Therapy with a combination of low doses of interleukin 12 and chloroquine completely cures blood-stage malaria, prevents severe anemia, and induces immunity to reinfection Infect Immun 1999 67: 513–519

    CAS  PubMed  PubMed Central  Google Scholar 

  4. Stevenson MM, Su Z, Sam H, Mohan K . Modulation of host responses to blood-stage malaria by interleukin-12: from therapy to adjuvant activity Microbes Infect 2001 3: 49–59

    Article  CAS  Google Scholar 

  5. Perkins DJ, Weinberg JB, Kremsner PG . Reduced interleukin-12 and transforming growth factor-beta 1 in severe childhood malaria: relationship of cytokine balance with disease severity J Infect Dis 2000 182: 988–992

    Article  CAS  Google Scholar 

  6. Huang D, Cancilla M, Morahan G . Complete primary structure, chromosomal localisation, and definition of polymorphisms of the gene encoding the human interleukin-12 p40 subunit Genes Immun 2000 1: 515–520

    Article  CAS  Google Scholar 

  7. Morahan G, Huang D, Ymer S et al. Linkage disequilibrium of a Type 1 diabetes susceptibility locus with a regulatory IL12B allele Nat Genet 2001 27: 218–221

    Article  CAS  Google Scholar 

  8. Anstey NM, Weinberg JB, Hassanali MY et al. Nitric oxide in Tanzanian children with malaria: inverse relationship between malaria severity and nitric oxide production/nitric oxide synthase type 2 expression J Exp Med 1996 184: 557–567

    Article  CAS  Google Scholar 

  9. Pain A, Urban BC, Kai O et al. A non-sense mutation in Cd36 gene is associated with protection from severe malaria Lancet 2001 357: 1502–1503

    Article  CAS  Google Scholar 

  10. Levesque MC, Hobbs MR, Anstey NM et al. A review of polymorphisms in the human gene for inducible nitric oxide synthase (NOS2) in patients with malaria Sepsis 2001 4: 217–231

    Article  Google Scholar 

  11. Sedegah M, Finkelman F, Hoffman SL . Interleukin 12 induction of interferon gamma-dependent protection against malaria Proc Natl Acad Sci USA 1994 91: 10700–10702

    Article  CAS  Google Scholar 

  12. Su Z, Stevenson MM . IL-12 is required for antibody-mediated protective immunity against blood-stage Plasmodium chabaudi AS malaria infection in mice J Immunol 2002 168: 1348–1355

    Article  CAS  Google Scholar 

  13. Perkins DJ, Kremsner PG, Schmid D, Misukonis MA, Kelly MA, Weinberg JB . Blood mononuclear cell nitric oxide production and plasma cytokine levels in healthy gabonese children with prior mild or severe malaria Infect Immun 1999 67: 4977–4981

    CAS  PubMed  PubMed Central  Google Scholar 

  14. Chiwakata CB, Hemmer CJ, Dietrich M . High levels of inducible nitric oxide synthase mRNA are associated with increased monocyte counts in blood and have a beneficial role in Plasmodium falciparum malaria Infect Immum 2000 68: 394–399

    Article  CAS  Google Scholar 

  15. Taramelli D, Basilico N, Pagani E et al. The heme moiety of malaria pigment (beta-hematin) mediates the inhibition of nitric oxide and tumor necrosis factor-alpha production by lipopolysaccharide-stimulated macrophages Exp Parasitol 1995 81: 501–511

    Article  CAS  Google Scholar 

  16. Craig A, Hastings I, Pain A, Roberts DJ . Genetics and malaria—more questions than answers Trends Parasitol 2001 17: 55–56

    Article  CAS  Google Scholar 

  17. Hall P, Levin A, Entwistle C, Knight S, Wasunna A, Brubaker G . B15 heterogeneity in East African blacks Tissue Antigens 1980 16: 326–332

    Article  CAS  Google Scholar 

  18. Hobbs M, Pole A, Anstey N . Whole genome amplification from field collected blood spots on filter paper submitted for publication

Download references

Acknowledgements

We thank Zhiqiang Wang for statistical advice, and Mushtaq Hassanali and Denis Manyenga for assistance with data collection. This paper is published with the approval of the Director of KEMRI.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to G Morahan.

Additional information

This work was financially supported by the National Health and Medical Research Council of Australia and by a Special Program Grant from the NHMRC and the Juvenile Diabetes Research Foundation; National Institutes of Health RO1 AI41764, NHMRC Scholarship (CSB) and the Wellcome Trust, UK. DJR is a Howard Hughes International Research Scholar. No author has a commercial or other association that might pose a conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Morahan, G., Boutlis, C., Huang, D. et al. A promoter polymorphism in the gene encoding interleukin-12 p40 (IL12B) is associated with mortality from cerebral malaria and with reduced nitric oxide production. Genes Immun 3, 414–418 (2002). https://doi.org/10.1038/sj.gene.6363909

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.gene.6363909

Keywords

This article is cited by

Search

Quick links